UBS Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.6K | Sell |
223
-4,436
| -95% | -$71.6K | ﹤0.01% | 8010 |
|
|
2025
Q1 | $97.8K | Buy |
4,659
+2,370
| +104% | +$49.8K | ﹤0.01% | 5797 |
|
|
2024
Q4 | $57K | Buy |
2,289
+1,605
| +235% | +$40K | ﹤0.01% | 5998 |
|
|
2024
Q3 | $11.6K | Sell |
684
-146
| -18% | -$2.47K | ﹤0.01% | 6462 |
|
|
2024
Q2 | $23.4K | Buy |
830
+815
| +5,433% | +$23K | ﹤0.01% | 6052 |
|
|
2024
Q1 | $4.5K | Buy |
15
+8
| +114% | +$2.4K | ﹤0.01% | 6448 |
|
|
2023
Q4 | $1.61K | Buy |
+7
| New | +$1.61K | ﹤0.01% | 7046 |
|
|
2023
Q3 | – | Sell |
-63
| Closed | -$11K | – | 8436 |
|
|
2023
Q2 | $11K | Sell |
63
-51
| -45% | -$8.91K | ﹤0.01% | 6039 |
|
|
2023
Q1 | $14.4K | Buy |
+114
| New | +$14.4K | ﹤0.01% | 6257 |
|
|
2022
Q4 | – | Sell |
-173
| Closed | -$10K | – | 9613 |
|
|
2022
Q3 | $10K | Buy |
+173
| New | +$10K | ﹤0.01% | 7321 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 9424 |
|
|
2022
Q1 | – | Sell |
-211
| Closed | -$30K | – | 9323 |
|
|
2021
Q4 | $30K | Buy |
+211
| New | +$30K | ﹤0.01% | 6289 |
|
|
2021
Q3 | – | Sell |
-103
| Closed | -$24K | – | 8513 |
|
|
2021
Q2 | $24K | Sell |
103
-172
| -63% | -$40.1K | ﹤0.01% | 6051 |
|
|
2021
Q1 | $83K | Sell |
275
-315
| -53% | -$95.1K | ﹤0.01% | 5116 |
|
|
2020
Q4 | $222K | Buy |
590
+161
| +38% | +$60.6K | ﹤0.01% | 4214 |
|
|
2020
Q3 | $132K | Sell |
429
-113
| -21% | -$34.8K | ﹤0.01% | 4210 |
|
|
2020
Q2 | $204K | Sell |
542
-119
| -18% | -$44.8K | ﹤0.01% | 3989 |
|
|
2020
Q1 | $151K | Sell |
661
-229
| -26% | -$52.3K | ﹤0.01% | 4095 |
|
|
2019
Q4 | $471K | Buy |
890
+462
| +108% | +$244K | ﹤0.01% | 3941 |
|
|
2019
Q3 | $185K | Sell |
428
-123
| -22% | -$53.2K | ﹤0.01% | 4416 |
|
|
2019
Q2 | $656K | Sell |
551
-189
| -26% | -$225K | ﹤0.01% | 3353 |
|
|
2019
Q1 | $922K | Buy |
740
+282
| +62% | +$351K | ﹤0.01% | 2990 |
|
|
2018
Q4 | $434K | Buy |
458
+275
| +150% | +$261K | ﹤0.01% | 3596 |
|
|
2018
Q3 | $263K | Buy |
183
+180
| +6,000% | +$259K | ﹤0.01% | 4040 |
|
|
2018
Q2 | $5K | Sell |
3
-1,251
| -100% | -$2.09M | ﹤0.01% | 6535 |
|
|
2018
Q1 | $2.04M | Buy |
1,254
+1,251
| +41,700% | +$2.03M | ﹤0.01% | 2542 |
|
|
2017
Q4 | $5K | Sell |
3
-20
| -87% | -$33.3K | ﹤0.01% | 6395 |
|
|
2017
Q3 | $32K | Buy |
23
+19
| +475% | +$26.4K | ﹤0.01% | 5216 |
|
|
2017
Q2 | $4K | Sell |
4
-14
| -78% | -$14K | ﹤0.01% | 6251 |
|
|
2017
Q1 | $10K | Sell |
18
-13
| -42% | -$7.22K | ﹤0.01% | 5679 |
|
|
2016
Q4 | $19K | Buy |
31
+24
| +343% | +$14.7K | ﹤0.01% | 5600 |
|
|
2016
Q3 | $5K | Buy |
+7
| New | +$5K | ﹤0.01% | 6188 |
|
|
2016
Q2 | – | Sell |
-12
| Closed | -$7K | – | 6832 |
|
|
2016
Q1 | $7K | Buy |
+12
| New | +$7K | ﹤0.01% | 5995 |
|
|
2015
Q4 | – | Sell |
-14
| Closed | -$8K | – | 6922 |
|
|
2015
Q3 | $8K | Sell |
14
-6
| -30% | -$3.43K | ﹤0.01% | 6039 |
|
|
2015
Q2 | $16K | Buy |
20
+9
| +82% | +$7.2K | ﹤0.01% | 5661 |
|
|
2015
Q1 | $9K | Buy |
+11
| New | +$9K | ﹤0.01% | 5915 |
|